Astrana Health Inc. Common Stock (ASTH) is a publicly traded Healthcare sector company. As of July 14, 2026, ASTH trades at $46.26 with a market cap of $2.32B and a P/E ratio of 104.12. ASTH moved -2.91% today. Year to date, ASTH is +90.79%; over the trailing twelve months it is +91.33%. Its 52-week range spans $18.08 to $51.60. Analyst consensus is strong buy with an average price target of $45.71. Rallies surfaces ASTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ASTH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $46.26 |
| Market Cap | $2.32B |
| P/E Ratio | 104.12 |
| EPS | $0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $51.60 |
| 52-Week Low | $18.08 |
| Volume | 3 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.18B |
| Net Income | $24.08M |
| Gross Margin | 0.00% |
9 analysts cover ASTH: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.71.